December 16, 2024 -- On December 10, JD Health, in collaboration with Merck, a globally renowned biopharmaceutical leader, began offering GLUCOPHAGE® XR (Reduce Mass), the metformin hydrochloride extended-release tablets, and became the first online pharmacy in China to provide the new antidiabetic medication developed by Merck. This launch signifies a major milestone in the partnership between JD Health and Merck, which is dedicated to enhancing the online availability and accessibility of innovative treatments for type 2 diabetes patients in China, thereby offering them a more convenient and effective medication experience.
GLUCOPHAGE® has been a cornerstone in the treatment of type 2 diabetes for over 60 years worldwide. The latest version of this medication is designed to enhance patient adherence by reducing the long-term burden of medication administration while maintaining its therapeutic benefits. The use of GSD sustained-release technology extends the time the medication remains in the stomach, reduces gastrointestinal irritation, and improves drug absorption. Additionally, the tablet is now smaller, has reduced volume by 30%, and has been transitioned from a capsule to a round shape, making it easier to swallow. It requires only once-daily administration, significantly enhancing patient convenience and safety.
At a glance
- Company
- JD Health
- Announcement
- Product
- Location
- China
Key figures
- Tablet volume reduction
- 30%
- GLUCOPHAGE® treatment history worldwide
- over 60 years
- Administration frequency
- once-daily
Products and programs
To celebrate the online launch collaboration, JD Health and Merck hosted a special release event for the new medication at the 7th China International Import Expo in November. This event followed their partnership agreement in September, which also marked the opening of Merck China’s self-operated flagship store on JD.com.
With a large user base, robust supply chain, and rich medical service resources, JD Health has become a preferred partner to launch many chronic disease medications online. By seamlessly integrating online and offline resources, JD Health ensures that new drug information reaches the right users swiftly, offering convenient purchasing options and improving drug accessibility and usage efficiency. Additionally, JD Health’s extensive logistics network ensures timely and secure delivery of medications, enhancing user experience and building trust.
If you detect any issues, problems, or errors in this press release content, kindly contact [email protected] to notify us (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). We will respond and rectify the situation in the next 8 hours.
In brief
JD Health and Merck began offering Merck’s GLUCOPHAGE® XR (Reduce Mass) diabetes medication through JD Health in China on December 10, according to the release. JD Health says it is the first online pharmacy in the country to provide the new medication. The companies’ collaboration follows a partnership agreement in September and the opening of Merck China’s self-operated store on JD.com. The extended-release metformin product uses GSD sustained-release technology, and the release says its tablet is smaller, 30% lower in volume, and designed for once-daily use. JD Health and Merck also held a launch event at the 7th China International Import Expo in November. The company says its online services and logistics network support access to medications.
Key takeaways
- JD Health and Merck began online sales of GLUCOPHAGE® XR (Reduce Mass) in China on December 10.
- JD Health says it is the first online pharmacy in China to offer the medication.
- The tablet’s volume is reduced by 30%, and the product is intended for once-daily administration.
- The launch follows a September partnership agreement and a November event at the China International Import Expo.
